Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000941540 | SCV001087429 | likely benign | Peroxisome biogenesis disorder, complementation group 7 | 2024-01-30 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001272155 | SCV001453850 | uncertain significance | Zellweger spectrum disorders | 2020-03-17 | no assertion criteria provided | clinical testing | |
Prevention |
RCV003913189 | SCV004735084 | likely benign | PEX10-related disorder | 2023-10-26 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |